Obesity influences rheumatoid arthritis diagnostic tests

Obesity causes patients to receive higher scores in blood tests used to diagnose rheumatoid arthritis even if they do not have the condition, researchers have warned.

Obese patients have higher levels of C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR), regardless of whether they have rheumatoid arthritis, researchers have found.

The study published in Arthritis Care & Research, said fat mass could push up CRP and ESR levels, which could be mistaken for arthritis disease activity.

Blood tests to determine CRP and ESR levels are used to assess levels of inflammation in the body, which in turn is used to diagnose rheumatoid arthritis or determine how effective treatment is.

Over 2,100 patients with rheumatoid arthritis were involved in the trial, which was compared with data from the general population.

Among women in the general population and those who had rheumatoid arthritis, CRP levels increased in line with BMI, becoming especially high in those with severe obesity, the researchers found. ESR levels also increased, but at a more modest rate.

In men with rheumatoid arthritis, lower BMI was associated with greater CRP and ESR, contrasting positive associations among men in the general population – who followed the same pattern as women.

Clinicians should keep the association in mind when testing patients, the researchers said.

Rheumatoid arthritis

Lead author Dr Michael George said: ‘Our results suggest that obesity may lead to increased levels of CRP and ESR in women with rheumatoid arthritis.

‘The increase in these levels of inflammation was not because rheumatoid arthritis was worse in these women. In fact, we found that obesity leads to very similar increases in these lab tests even in women without rheumatoid arthritis.

‘Physicians might assume that high levels of inflammation mean that a patient has rheumatoid arthritis or that their rheumatoid arthritis requires more treatment when in fact a mild increase in levels of inflammation could be due to obesity instead.’

GPC clinical and prescribing lead Dr Andrew Green said doctors should look at changes over time in CRP and ESR values to diagnose patients and take into account individual differences.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Just published

GP Job of the Week: Lead GP, urgent care centre, east London

GP Job of the Week: Lead GP, urgent care centre, east London

Greenbrook Healthcare is looking to appoint a lead GP to its clinical leadership...

NHS England says it will avoid top-down approach to PCNs

NHS England says it will avoid top-down approach to PCNs

NHS England will not issue national guidance to primary care networks (PCNs) about...

Capita admits to further cervical screening administration errors

Capita admits to further cervical screening administration errors

The BMA has again demanded that Capita be stripped of its contract to provide GP...

GPC Wales appoints new chair

GPC Wales appoints new chair

Dr Phil White has been appointed the new chair of GPC Wales.

Nine in 10 GPs say appraisal improves patient care

Nine in 10 GPs say appraisal improves patient care

The vast majority of GPs believe annual appraisal helps to improve patient care and...

GPs have a key role to play in helping people back into work

GPs have a key role to play in helping people back into work

Brief interventions by health professionals can help people to achieve their working...